Losartan potassium - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for losartan potassium and what is the scope of patent protection?
Losartan potassium
is the generic ingredient in three branded drugs marketed by Scienture, Organon, Aiping Pharm Inc, Alembic Pharms Ltd, Apotex, Apotex Corp, Aurobindo Pharma, Chartwell Rx, Granules, Hetero Labs Ltd V, Hikma, Hisun Pharm Hangzhou, Ipca Labs Ltd, Jubilant Cadista, Lupin Ltd, Macleods Pharms Ltd, Micro Labs, MSN, Mylan, Prinston Inc, Strides Pharma, Teva, Torrent Pharms, Unichem, Watson Labs, and Zydus Pharms Usa Inc, and is included in twenty-six NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.Losartan potassium has one patent family member in one country.
There are thirty-eight drug master file entries for losartan potassium. Forty-nine suppliers are listed for this compound.
Summary for losartan potassium
International Patents: | 1 |
US Patents: | 2 |
Tradenames: | 3 |
Applicants: | 26 |
NDAs: | 26 |
Drug Master File Entries: | 38 |
Finished Product Suppliers / Packagers: | 49 |
Raw Ingredient (Bulk) Api Vendors: | 139 |
Clinical Trials: | 86 |
Patent Applications: | 4,107 |
Drug Prices: | Drug price trends for losartan potassium |
Drug Sales Revenues: | Drug sales revenues for losartan potassium |
What excipients (inactive ingredients) are in losartan potassium? | losartan potassium excipients list |
DailyMed Link: | losartan potassium at DailyMed |
Recent Clinical Trials for losartan potassium
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Gadjah Mada University | Phase 1/Phase 2 |
Second Affiliated Hospital, School of Medicine, Zhejiang University | N/A |
Steadman Philippon Research Institute | Phase 2 |
Pharmacology for losartan potassium
Drug Class | Angiotensin 2 Receptor Blocker |
Mechanism of Action | Angiotensin 2 Receptor Antagonists |
Medical Subject Heading (MeSH) Categories for losartan potassium
Anatomical Therapeutic Chemical (ATC) Classes for losartan potassium
US Patents and Regulatory Information for losartan potassium
Expired US Patents for losartan potassium
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Organon | COZAAR | losartan potassium | TABLET;ORAL | 020386-002 | Apr 14, 1995 | 5,138,069*PED | ⤷ Try for Free |
Organon | COZAAR | losartan potassium | TABLET;ORAL | 020386-001 | Apr 14, 1995 | 5,138,069*PED | ⤷ Try for Free |
Organon | COZAAR | losartan potassium | TABLET;ORAL | 020386-002 | Apr 14, 1995 | 5,608,075 | ⤷ Try for Free |
Organon | COZAAR | losartan potassium | TABLET;ORAL | 020386-002 | Apr 14, 1995 | 5,608,075*PED | ⤷ Try for Free |
Organon | COZAAR | losartan potassium | TABLET;ORAL | 020386-002 | Apr 14, 1995 | 5,210,079*PED | ⤷ Try for Free |
Organon | COZAAR | losartan potassium | TABLET;ORAL | 020386-003 | Oct 13, 1998 | 5,153,197*PED | ⤷ Try for Free |
Organon | COZAAR | losartan potassium | TABLET;ORAL | 020386-001 | Apr 14, 1995 | 5,608,075 | ⤷ Try for Free |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for losartan potassium
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
World Intellectual Property Organization (WIPO) | 2022076746 | ⤷ Try for Free | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for losartan potassium
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0733366 | 98C0030 | Belgium | ⤷ Try for Free | PRODUCT NAME: KALII LOSARTAN, HYDROCHLOROTHIAZIDUM; NAT. REGISTRATION NO/DATE: 922 IS 174 F 3 19980223; FIRST REGISTRATION: FR 338 520.7 19950215 |
0733366 | SZ 25/1998 | Austria | ⤷ Try for Free | PRODUCT NAME: LOSARTAN-KALIUM UND HYDROCHLOROTHIAZID |
0480717 | 98C0025 | Belgium | ⤷ Try for Free | PRODUCT NAME: LOSARTAN POTASSIUM; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 20 037 19950215; FIRST REGISTRATION: FR - NL 20 037 19950215 |
0253310 | C950009 | Netherlands | ⤷ Try for Free | PRODUCT NAME: LOSARTAN, DESGEWENST IN DE VORM VAN EEN AANVAARDBAAR ZOUT, IN HET BIJZONDER HET KALIUMZOUT; NAT. REGISTRATION NO/DATE: RVG 17617 19950314; FIRST REGISTRATION: SE 12209 19940902 |
0733366 | SPC/GB98/031 | United Kingdom | ⤷ Try for Free | PRODUCT NAME: 2-BUTYL-4-CHLORO-1-((2'-(1H-TETRAZOL-5-YL) BIPHENYL-4-YL)-METHYL)-5-(HYDROXYMETHYL)IMIDAZOLE (LOSARTAN),OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, IN PARTICULAR A POTASSIUM SALT( LOSARTAN POTASSIUM) AND HYDROCHLOROTHIAZIDE,; REGISTERED: FR 338520.7 19950215; FR 558453.7 19950215; UK 00025/0338 19960412 |
0253310 | 96C0020 | Belgium | ⤷ Try for Free | PRODUCT NAME: KALII LOSARTAN; NAT. REGISTRATION NO/DATE: 922 IS 169 F3 19960130; FIRST REGISTRATION: SE 12209 19940902 |
0253310 | SZ 16/1996 | Austria | ⤷ Try for Free | PRODUCT NAME: LOSARTAN-KALIUM |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Market Dynamics and Financial Trajectory of Losartan Potassium
More… ↓
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.